Erratum to: Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab

被引:0
|
作者
Koichi Kamei
Masao Ogura
Mai Sato
Mayumi Sako
Kazumoto Iijima
Shuichi Ito
机构
[1] National Center for Child Health and Development,Division of Nephrology and Rheumatology
[2] National Center for Child Health and Development,Division for Clinical Trials, Department of Development Strategy, Center for Social and Clinical Research, National Research Institute for Child Health and Development
[3] Kobe University Graduate School of Medicine,Department of Pediatrics
[4] Yokohama City University,Department of Pediatrics
来源
Pediatric Nephrology | 2016年 / 31卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:167 / 167
相关论文
共 50 条
  • [1] Long-term prognosis and risk factors for relapse in patients with steroid-dependent nephrotic syndrome treated with rituximab
    Kamei, Koichi
    Okada, Mari
    Miyazono, Akinori
    Sato, Mai
    Fujimaru, Takuya
    Ogura, Masao
    Ito, Shuichi
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1616 - 1616
  • [2] Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab (vol 31, pg 89, 2016)
    Kamei, Koichi
    Ogura, Masao
    Sato, Mai
    Sako, Mayumi
    Iijima, Kazumoto
    Ito, Shuichi
    PEDIATRIC NEPHROLOGY, 2016, 31 (01) : 167 - 167
  • [3] Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment
    Shuichiro Fujinaga
    Daishi Hirano
    Akira Mizutani
    Koji Sakuraya
    Akifumi Yamada
    Shunsuke Sakurai
    Toshiaki Shimizu
    Clinical and Experimental Nephrology, 2017, 21 : 671 - 676
  • [4] Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment
    Fujinaga, Shuichiro
    Hirano, Daishi
    Mizutani, Akira
    Sakuraya, Koji
    Yamada, Akifumi
    Sakurai, Shunsuke
    Shimizu, Toshiaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (04) : 671 - 676
  • [5] Long-term outcome of children treated with rituximab for steroid-dependent or resistant idiopahtic nephrotic syndrome in Shanghai single center
    Sun, Li
    Xu, Hong
    Shen, Qian
    Cao, Qi
    Rao, Jia
    Liu, Mei Hai
    Fang, Yan Xiao
    Chen, Jing
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1606 - 1606
  • [6] Efficacy and safety of long-term treatment of rituximab in children with steroid-dependent nephrotic syndrome
    Kang, H. G.
    Kim, J. H.
    Ahn, Y. H.
    Park, E.
    Ha, I-S.
    Cheong, H. I.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1866 - 1866
  • [7] Rituximab for steroid-dependent nephrotic syndrome
    Beco, A.
    Castro-Ferreira, I.
    Coentrao, L.
    Neto, R.
    Sampaio, S.
    Pestana, M.
    CLINICAL NEPHROLOGY, 2010, 74 (04) : 308 - 310
  • [8] Rituximab in Steroid-dependent Nephrotic Syndrome
    El Koumi, Mohamed
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (06) : 502 - 506
  • [9] Long-term effects of immunosuppressants in steroid-dependent nephrotic syndrome
    Atsushi Takeda
    Hiroaki Ohgushi
    Fumio Niimura
    Hidetomo Matsutani
    Pediatric Nephrology, 1998, 12 : 746 - 750
  • [10] Long-term effects of immunosuppressants in steroid-dependent nephrotic syndrome
    Takeda, A
    Ohgushi, H
    Niimura, F
    Matsutani, H
    PEDIATRIC NEPHROLOGY, 1998, 12 (09) : 746 - 750